Singh Tajinder K, Ties Daan, Groot Hilde E, Krabbe Paul F M, van der Harst Pim
Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Int J Cardiol Cardiovasc Risk Prev. 2024 Dec 11;24:200357. doi: 10.1016/j.ijcrp.2024.200357. eCollection 2025 Mar.
Assessment of health-related quality of life (HRQoL) in patients with cardiovascular disease (CVD) is impaired by limitations of current patient-reported outcome measures (PROMs). We developed the first cardiovascular disease (CVD) specific electronic PROM for which health items were derived by a fully patient-centered method. This paper reports on the measurement of HRQoL in CVD patients by a novel developed electronic patient-centred PROM based on a preference-based measurement model.
In an earlier patient-based study nine health items were selected as most important to CVD patients. These items were assessed in the novel preference-based PROM of this study. CVD patients registered with a Dutch patient organization were asked to rate their health state. We compared HRQoL between subgroups of age, gender and CVD. A total of 554 patients participated in this study. The patient reported health items "worry", "self-reliance" and "sexuality" had the highest impact on HRQoL of CVD patients. Median HRQoL was better for men compared to woman (-17.04, IQR: 31.47 to -3.91 vs. -25.22; IQR: 42.06 to -9.53, p = 0.003). Best and worst HRQoL were observed in patients with an unknown or other CVD disease (-15.61, IQR: 28.52 to -3.91) followed by individuals with coronary artery disease (-16.99, IQR: 38.08 - 0.00) and heart failure (-24.27, IQR: 42.64 to -12.98).
This novel patient-centred, preference-based, CVD-specific PROM accurately measures HRQoL by taking individual health preferences into account and tackling limitations of current PROMs. This PROM is therefore promising to evaluate interventions and optimize personalized therapies.
目前患者报告结局测量指标(PROMs)的局限性影响了心血管疾病(CVD)患者健康相关生活质量(HRQoL)的评估。我们开发了首个心血管疾病特异性电子PROM,其健康项目是通过完全以患者为中心的方法得出的。本文报告了基于偏好测量模型新开发的以患者为中心的电子PROM对CVD患者HRQoL的测量。
在早期基于患者的研究中,九个健康项目被选为对CVD患者最重要的项目。这些项目在本研究新的基于偏好的PROM中进行评估。向在荷兰患者组织注册的CVD患者询问其健康状况评分。我们比较了年龄、性别和CVD亚组之间的HRQoL。共有554名患者参与了本研究。患者报告的健康项目“担忧”“自立”和“性能力”对CVD患者的HRQoL影响最大。男性的HRQoL中位数优于女性(-17.04,四分位距:31.47至-3.91,对比-25.22;四分位距:42.06至-9.53,p = 0.003)。HRQoL最佳和最差的是患有未知或其他CVD疾病的患者(-15.61,四分位距:28.52至-3.91),其次是冠状动脉疾病患者(-16.99,四分位距:38.08至0.00)和心力衰竭患者(-24.27,四分位距:42.64至-12.98)。
这种新型的以患者为中心、基于偏好、CVD特异性的PROM通过考虑个体健康偏好并解决当前PROM的局限性,准确测量了HRQoL。因此,该PROM有望用于评估干预措施并优化个性化治疗。